Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

被引：12
|
作者：
Gruson, Damien [1 ,2 ,3 ]
Ferracin, Benjamin [2 ,3 ]
Ahn, Sylvie A. [4 ,5 ]
Rousseau, Michel F. [4 ,5 ]
机构：
[1] Clin Univ St Luc, Inst Rech Expt & Clin, Pole Rech Endocrinol Diabet & Nutr, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Dept Lab Med, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium
[5] Catholic Univ Louvain, Inst Rech Expt & Clin, Div Cardiol, Pole Rech Cardiovasc, B-1200 Brussels, Belgium
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 189卷
关键词：
FGF-23; Galectin-3; ST2; NT-proBNP; BNP; Biomarker; Heart failure; Prognosis; EXPRESSION; PREDICTOR;
D O I：
10.1016/j.ijcard.2015.04.074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：185 / 187
页数：3
相关论文
共 50 条
  • [41] Soluble ST2 as a possible biomarker for inflammation in patients with acute heart failure
    Lai, Jiacheng
    Huang, Chongjian
    Li, Bin
    Han, Yongsheng
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (03) : 186 - 192
  • [42] Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
    Yalta, Kenan
    Zorkun, Cafer
    INDIAN HEART JOURNAL, 2018, 70 (01) : 196 - 196
  • [43] Soluble ST2 proteins in male cachectic patients with chronic heart failure
    Sobieszek, Grzegorz
    Powrozek, Tomasz
    Jaroszynski, Andrzej
    Skwarek-Dziekanowska, Aneta
    Rahnama-Hezavah, Mansur
    Malecka-Massalska, Teresa
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (03) : 886 - 893
  • [44] Influence of galectin-3 and soluble ST-2 on risk of death and heart failure hospitalization in patients after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
    Tyminska, A. Agata
    Kaplon-Cieslicka, A.
    Ozieranski, K.
    Budnik, M.
    Wancerz, A.
    Sypien, P.
    Balsam, P.
    Peller, M.
    Opolski, G.
    Filipiak, K. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 224 - 225
  • [45] Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients
    Wojciechowska, Celina
    Romuk, Ewa
    Nowalany-Kozielska, Ewa
    Jachec, Wojciech
    HELLENIC JOURNAL OF CARDIOLOGY, 2017, 58 (05) : 350 - 359
  • [46] Clinical correlates of Galectin-3, ST2 and NT-proBNP: head-to-head comparison
    Paradies, V.
    Iacoviello, M.
    Leone, M.
    Citarelli, G.
    Rizzo, C.
    Valle, R.
    Aspromonte, N.
    Caldarola, P.
    Gesualdo, L.
    Di Serio, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 214 - 214
  • [47] Soluble ST2 for predicting heart failure, atrial fibrillation and death in patients with coronary heart disease with or without renal insufficiency
    Li, Huiying
    Zhu, Qiwei
    Bai, Jing
    Chen, Jianqiao
    Zhu, Zifan
    Hao, Benchuan
    Wang, Wei
    Bai, Yongyi
    Liu, Hongbin
    HELIYON, 2024, 10 (09)
  • [48] GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD
    Tuegel, Courtney
    Katz, Ronit
    Alam, Mariam
    Bhat, Zeenat
    Bellovich, Keith
    de Boer, Ian
    Brosius, Frank
    Gadegbeku, Crystal
    Gipson, Debbie
    Hawkins, Jennifer
    Himmelfarb, Jonathan
    Ju, Wenjun
    Kestenbaum, Bryan
    Kretzler, Matthias
    Robinson-Cohen, Cassianne
    Steigerwalt, Susan
    Bansal, Nisha
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 72 (04) : 519 - 528
  • [49] Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery
    Hofer, Felix
    Hammer, Andreas
    Pailer, Ulrike
    Koller, Lorenz
    Kazem, Niema
    Steinacher, Eva
    Steinlechner, Barbara
    Andreas, Martin
    Laufer, Guenther
    Wojta, Johann
    Zelniker, Thomas A.
    Hengstenberg, Christian
    Niessner, Alexander
    Sulzgruber, Patrick
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (05):
  • [50] Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT
    Skali, Hicham
    Gerwien, Robert
    Meyer, Timothy E.
    Snider, James V.
    Solomon, Scott D.
    Stolen, Craig M.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2016, 9 (5-6) : 421 - 428
12345